185 related articles for article (PubMed ID: 4708012)
1. Abnormal structures in circulating lymphocytes from patients with systemic lupus erythematosus and related diseases.
Grrimley PM; Decker JL; Michelitch HJ; Frantz MM
Arthritis Rheum; 1973; 16(3):313-23. PubMed ID: 4708012
[No Abstract] [Full Text] [Related]
2. [Fibrin fibrinogen degradation products in the blood in systemic lupus erythematosus and other major collagen diseases].
Wysocka K; Kiczak J
Reumatologia; 1982; 20(1-2):15-21. PubMed ID: 7163659
[No Abstract] [Full Text] [Related]
3. Serum levels of cartilage oligomeric matrix protein are elevated in rheumatoid arthritis, but not in inflammatory rheumatic diseases such as psoriatic arthritis, reactive arthritis, Raynaud's syndrome, scleroderma, systemic lupus erythematosus, vasculitis and Sjögren's syndrome.
Skoumal M; Haberhauer G; Feyertag J; Kittl EM; Bauer K; Dunky A
Arthritis Res Ther; 2004; 6(2):73-4. PubMed ID: 15059267
[No Abstract] [Full Text] [Related]
4. [Virus-like endoplasmatic structures in lupus erythematosus and in various other diseases of unknown etiology].
Kerl H; Auböck L
Hautarzt; 1973 Mar; 24(3):95-105. PubMed ID: 4713269
[No Abstract] [Full Text] [Related]
5. Scleroderma and its relationship to the "collagenoses": dermatomyositis, lupus erythematosus, rheumatoid arthritis and Sjogren's syndrome.
TUFFANELLI DL
Am J Med Sci; 1962 Feb; 243():133-46. PubMed ID: 13923027
[No Abstract] [Full Text] [Related]
6. [Hemorheologic disturbances and circulating immune complexes in patients with rheumatic diseases].
Loskutova TT; Koreshkov GG; Nasonov EL; Zakharchenko VN; Larionov SM
Ter Arkh; 1989; 61(5):51-5. PubMed ID: 2781490
[No Abstract] [Full Text] [Related]
7. Elevated serum CA125 in progressive systemic sclerosis with pleural effusion.
Kimura K; Ezoe K; Yokozeki H; Katayama I; Nishioka K
J Dermatol; 1995 Jan; 22(1):28-31. PubMed ID: 7897020
[TBL] [Abstract][Full Text] [Related]
8. [Studies on plasma proteins in diffuse connective tissue diseases using electrophoresis in polyacrylamide gel].
Cebecauer L; Zitnan D
Z Rheumaforsch; 1969; 28(5):227-31. PubMed ID: 4184267
[No Abstract] [Full Text] [Related]
9. Virus-like structures in lymphocytes of patients with systemic and discoid lupus erythematosus.
Goodman JR; Sylvester RA; Talal N; Tuffanelli DL
Ann Intern Med; 1973 Sep; 79(3):396-402. PubMed ID: 4748256
[No Abstract] [Full Text] [Related]
10. Variations in the morphological patterns of "autoimmune" nuclear fluorescence.
BECK JS
Lancet; 1961 Jun; 1(7188):1203-5. PubMed ID: 13688397
[No Abstract] [Full Text] [Related]
11. [Changes in the blood protein and amino acid levels in rheumatic diseases].
Shevel' EIa; Bagirova GG; Shevel' VA; Bagirova VV
Ter Arkh; 1982; 54(10):87-9. PubMed ID: 7179129
[No Abstract] [Full Text] [Related]
12. COLLAGEN DISEASES AND THE NERVOUS SYSTEM.
GLASER GH
Med Clin North Am; 1963 Nov; 47():1475-95. PubMed ID: 14078159
[No Abstract] [Full Text] [Related]
13. Surfactant protein D (SP-D) and systemic scleroderma (SSc).
Maeda M; Ichiki Y; Aoyama Y; Kitajima Y
J Dermatol; 2001 Sep; 28(9):467-74. PubMed ID: 11603386
[TBL] [Abstract][Full Text] [Related]
14. Profiles of antinuclear antibodies in systemic rheumatic diseases.
Notman DD; Kurata N; Tan EM
Ann Intern Med; 1975 Oct; 83(4):464-9. PubMed ID: 1080976
[TBL] [Abstract][Full Text] [Related]
15. RELATIONSHIP OF SYSTEMIC LUPUS ERYTHEMATOSUS TO RHEUMATOID ARTHRITIS, DISCOID LUPUS ERYTHEMATOSUS, AND SJOEGREN'S SYNDROME: A CLINICAL STUDY.
BENCZE G; LAKATOS L
Ann Rheum Dis; 1963 Jul; 22(4):273-5. PubMed ID: 14043591
[No Abstract] [Full Text] [Related]
16. [Studies on the LE factor].
Bencze G
Med Monatsschr; 1969 Nov; 23(11):494-7. PubMed ID: 4190096
[No Abstract] [Full Text] [Related]
17. ANTI-NUCLEAR-FACTORS (ANF) AS DETERMINED BY THE IMMUNO-FLUORESCENT-ANTIBODY TECHNIQUE.
FABER V; ELLING P
Acta Med Scand; 1965 Mar; 177():309-19. PubMed ID: 14281788
[No Abstract] [Full Text] [Related]
18. THE RENAL ASPECTS OF THE COLLAGEN DISEASES.
PEARL MA; CARVAJAL E; MCCRACKEN BH
Am J Med Sci; 1963 Jul; 246():84-103. PubMed ID: 14046019
[No Abstract] [Full Text] [Related]
19. Circulating soluble CD30 levels in primary Sjögren's syndrome, SLE and rheumatoid arthritis.
Ichikawa Y; Yoshida M; Yamada C; Horiki T; Hoshina Y; Uchiyama M
Clin Exp Rheumatol; 1998; 16(6):759-60. PubMed ID: 9844777
[No Abstract] [Full Text] [Related]
20. The clinical utility of serum IL-35 in patients with polymyositis and dermatomyositis.
Yin L; Ge Y; Yang H; Peng Q; Lu X; Zhang Y; Wang G
Clin Rheumatol; 2016 Nov; 35(11):2715-2721. PubMed ID: 27502600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
